Low prevalence of anti-RNA polymerase III antibodies in a French scleroderma population: anti-RNA polymerase III scleroderma.

[1]  R. Burlingame,et al.  Anti-RNA polymerase III antibodies in patients with systemic sclerosis detected by indirect immunofluorescence and ELISA , 2008, Rheumatology.

[2]  M. Hudson,et al.  Antibodies to RNA polymerase III in systemic sclerosis detected by ELISA. , 2007, The Journal of rheumatology.

[3]  A. Tincani,et al.  Validation of a new immunoenzymatic method to detect antibodies to RNA polymerase III in systemic sclerosis. , 2007, Clinical and experimental rheumatology.

[4]  T. Medsger,et al.  Enzyme-linked immunosorbent assay for detection of anti-RNA polymerase III antibody: analytical accuracy and clinical associations in systemic sclerosis. , 2005, Arthritis and rheumatism.

[5]  R. Silver,et al.  HLA class II alleles in systemic sclerosis patients with anti-RNA polymerase I/III antibody: associations with subunit reactivities. , 2003, The Journal of rheumatology.

[6]  Brenda W Gillespie,et al.  Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. , 2003, Arthritis and rheumatism.

[7]  John D Reveille,et al.  Evidence-based guidelines for the use of immunologic tests: anticentromere, Scl-70, and nucleolar antibodies. , 2003, Arthritis and rheumatism.

[8]  R. Caporali,et al.  Autoantibodies to RNA-polymerases in Italian patients with systemic sclerosis. , 2003, Clinical and experimental rheumatology.

[9]  Y. Kawakami,et al.  Identification of an immunodominant epitope on RNA polymerase III recognized by systemic sclerosis sera: application to enzyme-linked immunosorbent assay. , 2002, Arthritis and rheumatism.

[10]  M. Alavi,et al.  Coexistence of antitopoisomerase I and anticentromere antibodies in patients with systemic sclerosis , 2002, Annals of the rheumatic diseases.

[11]  T. Medsger,et al.  Autoantibodies to RNA polymerases recognize multiple subunits and demonstrate cross-reactivity with RNA polymerase complexes. , 1999, Arthritis and rheumatism.

[12]  G. Komatireddy,et al.  Analysis of autoantibodies against RNA polymerases using immunoaffinity-purifed RNA polymerase I, II, and III antigen in an enzyme-linked immunosorbent assay. , 1998, Clinical immunology and immunopathology.

[13]  T. Medsger,et al.  Racial differences in the distribution of systemic sclerosis-related serum antinuclear antibodies. , 1994, Arthritis and rheumatism.

[14]  T. Medsger,et al.  Autoantibody Reactive with RNA Polymerase III in Systemic Sclerosis , 1993, Annals of Internal Medicine.

[15]  T. Mimori,et al.  Autoantibody reactive with three classes of RNA polymerases in sera from patients with systemic sclerosis. , 1993, The Journal of clinical investigation.

[16]  F. Arnett.  Revised criteria for the classification of rheumatoid arthritis. , 1990, Orthopedic nursing.

[17]  T. Medsger,et al.  Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. , 1988, The Journal of rheumatology.

[18]  E. Tan,et al.  Diversity of antinuclear antibodies in progressive systemic sclerosis. Anti-centromere antibody and its relationship to CREST syndrome. , 1980, Arthritis and rheumatism.

[19]  A. Masi.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). , 1980, Bulletin on the rheumatic diseases.

[20]  James F. Fries,et al.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. , 1980, Arthritis and rheumatism.

[21]  T. Medsger,et al.  Disease subsets, antinuclear antibody profile, and clinical features in 127 French and 247 US adult patients with systemic sclerosis. , 2007, The Journal of rheumatology.

[22]  C. Denton,et al.  Anti-RNA polymerases and other autoantibody specificities in systemic sclerosis. , 1998, British journal of rheumatology.